InvestorsHub Logo
icon url

DewDiligence

10/08/14 12:13 PM

#182579 RE: biocqr #182578

Similar MoA argument doubting the efficacy of lamividune in treating Ebola: #msg-106684875.
icon url

biomaven0

10/08/14 2:51 PM

#182583 RE: biocqr #182578

>>with the Dallas patient death we may have an answer

I really don't think so - the guy was already in organ failure, and his temperature and blood pressure had normalized.

>But Ebola is not a DNA virus

They say it works well in vitro and I have no reason to doubt them.

It is possible that there is an overlap between the RNA and DNA polymerases used by viruses. There are some commonalities in structure:

http://en.wikipedia.org/wiki/RNA-dependent_RNA_polymerase
icon url

DewDiligence

10/29/14 6:21 PM

#183348 RE: biocqr #182578

CMRX selling $121M* of stock at unspecified price in underwritten offering:

http://finance.yahoo.com/news/chimerix-announces-commencement-public-offering-205527733.html

*Assuming exercise of underwriter’s option.